BR112012004945A2 - bacteriófago novo e composição antibacteriana compreendendo o mesmo - Google Patents

bacteriófago novo e composição antibacteriana compreendendo o mesmo

Info

Publication number
BR112012004945A2
BR112012004945A2 BR112012004945A BR112012004945A BR112012004945A2 BR 112012004945 A2 BR112012004945 A2 BR 112012004945A2 BR 112012004945 A BR112012004945 A BR 112012004945A BR 112012004945 A BR112012004945 A BR 112012004945A BR 112012004945 A2 BR112012004945 A2 BR 112012004945A2
Authority
BR
Brazil
Prior art keywords
salmonella
novel bacteriophage
same
antibacterial composition
bacteria
Prior art date
Application number
BR112012004945A
Other languages
English (en)
Other versions
BR112012004945B8 (pt
BR112012004945B1 (pt
Inventor
Choi Hyang
Hye Kang In
Tae Park Min
An Shin Soo
Jin Choi Su
Wook Cho Young
Original Assignee
Cj Cheiljedang Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cj Cheiljedang Corp filed Critical Cj Cheiljedang Corp
Publication of BR112012004945A2 publication Critical patent/BR112012004945A2/pt
Publication of BR112012004945B1 publication Critical patent/BR112012004945B1/pt
Publication of BR112012004945B8 publication Critical patent/BR112012004945B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/76Viruses; Subviral particles; Bacteriophages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10321Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00Bacteriophages
    • C12N2795/00011Details
    • C12N2795/10011Details dsDNA Bacteriophages
    • C12N2795/10311Siphoviridae
    • C12N2795/10332Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

''bacteriófago novo e composição antibacterana compreendendo o mesmo'' está revelado neste um bacteriófago novo que tem uma atividade específica contra uma ou mais bactérias salmonella selecionadas do grupo consistindo em salmonella enteritidis, salmonella typhimurium, salmonella gallinarum, e salmonella pullorum sem afetar bactérias benéficas. também estão revelados neste, composições, ração animal ou água para beber, limpadores e desinfetantes para prevenção e tratamento de doenças infecciosas causadas por salmonella enteritidis, salmonella typhimurium, salmonella gallinarum ou salmonella pullorum incluindo salmonelose, intoxicação alimentar por salmonella, tifo aviário e pulorose ou para controlar as bactérias de salmonela.
BR112012004945A 2009-09-03 2010-09-03 composição para prevenção ou tratamento de doenças infecciosas, comida para animal ou água potável,sanitizante e produto de limpeza BR112012004945B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23974809P 2009-09-03 2009-09-03
US61/239,748 2009-09-03
PCT/KR2010/005999 WO2011028059A2 (en) 2009-09-03 2010-09-03 Novel bacteriophage and antibacterial composition comprising the same

Publications (3)

Publication Number Publication Date
BR112012004945A2 true BR112012004945A2 (pt) 2017-07-18
BR112012004945B1 BR112012004945B1 (pt) 2020-11-17
BR112012004945B8 BR112012004945B8 (pt) 2021-05-25

Family

ID=43625259

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012004945A BR112012004945B8 (pt) 2009-09-03 2010-09-03 composição para prevenção ou tratamento de doenças infecciosas, comida para animal ou água potável,sanitizante e produto de limpeza

Country Status (7)

Country Link
US (1) US8329442B2 (pt)
EP (1) EP2475377B1 (pt)
JP (1) JP5613767B2 (pt)
CN (1) CN102596219B (pt)
BR (1) BR112012004945B8 (pt)
ES (1) ES2562640T3 (pt)
WO (1) WO2011028059A2 (pt)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201114104D0 (en) * 2011-08-17 2011-09-28 Univ Nottingham Salmonella phage
PL217019B1 (pl) 2011-08-25 2014-06-30 Proteon Pharmaceuticals Spółka Akcyjna Sposób otrzymywania szczepu bakteriofaga, specyficzne szczepy bakteriofagowe oraz ich zastosowanie
KR101432872B1 (ko) * 2011-09-20 2014-08-27 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
EP2781220A1 (en) * 2013-03-18 2014-09-24 PTC Phage Technology Center GmbH Bacteriophages against Salmonella and their use
JP6112961B2 (ja) * 2013-05-09 2017-04-12 サラヤ株式会社 サルモネラ属菌に対して溶菌性を示す新規バクテリオファージ、及びそれを含有する組成物
KR101591789B1 (ko) * 2014-04-15 2016-02-04 씨제이제일제당(주) 신규 박테리오파지 및 이를 포함하는 조성물
US11058131B2 (en) 2015-04-16 2021-07-13 Kennesaw State University Research And Service Foundation, Inc. Escherichia coli O157:H7 bacteriophage Φ241
CN109666654B (zh) * 2015-06-09 2022-05-31 菲吉乐科(南京)生物科技有限公司 新的噬菌体、其组合物以及它们的制备方法和应用
WO2017089947A2 (es) 2015-11-25 2017-06-01 Universidad De Los Andes Composición que comprende bacteriófagos para reducir, eliminar y/o prevenir salmonella enteritidis, salmonella typhimurium y salmonella paratyphi b
CN108220249A (zh) * 2016-12-12 2018-06-29 上海交通大学医学院附属第九人民医院 长尾噬菌体及其获得方法和应用
KR102016919B1 (ko) * 2016-12-23 2019-09-02 주식회사 옵티팜 신규한 살모넬라균 특이 박테리오파지 sc1 및 이를 포함하는 항균 조성물
CN108359644B (zh) * 2018-02-07 2019-08-02 青岛诺安百特生物技术有限公司 一种宽谱沙门氏菌噬菌体及其应用
CN108707185B (zh) * 2018-05-24 2022-02-11 华南理工大学 一种延长噬菌体血液循环时间的多肽
WO2019227266A1 (zh) * 2018-05-28 2019-12-05 华南理工大学 一种延长噬菌体血液循环时间的多肽
CN111254121B (zh) * 2020-03-10 2022-03-18 青岛诺安百特生物技术有限公司 一种沙门氏菌噬菌体及在防治沙门氏菌感染的疾病的药物中的应用
CN112795544B (zh) * 2021-02-05 2022-08-12 山东仙普爱瑞科技股份有限公司 一株跨属烈性噬菌体、制备工艺及其在防治猪副伤寒和鸡白痢的应用
CN113230283A (zh) * 2021-04-01 2021-08-10 石河子大学 一种鸡大肠杆菌治疗性微生态制剂及其制备与应用
CN113980914B (zh) * 2021-12-06 2024-05-10 青岛新万福食品有限公司 一种宽裂解谱噬菌体及其在肉类冷冻保鲜中的应用
WO2024025936A2 (en) * 2022-07-26 2024-02-01 Board Of Trustees Of Michigan State University Development of carbohydrate-based anti-salmonella vaccines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000508322A (ja) 1996-04-15 2000-07-04 エヌワイエムオーエックス コーポレーション バクテリオファージを含有する組成物および感染症を治療するためのバクテリオファージの使用方法
US6485902B2 (en) 2000-06-06 2002-11-26 Thomas E. Waddell Use of bacteriophages for control of escherichia coli O157
US20070054357A1 (en) * 2005-09-06 2007-03-08 Pasternack Gary R Identification of useful bacteriophage
KR100941891B1 (ko) * 2007-09-20 2010-02-16 주식회사 인트론바이오테크놀로지 살모넬라 엔테리티디스 감염 박테리오파지로부터 선별된살모넬라 특이적 사멸능을 갖는 신규한 박테리오파지
KR100943041B1 (ko) * 2007-09-20 2010-02-19 재단법인서울대학교산학협력재단 시포비리대에 속하는 박테리오파지 및 이를 포함하는 세균사멸용 조성물
KR101151532B1 (ko) * 2008-12-24 2012-05-30 씨제이제일제당 (주) 신규한 박테리오파지 및 이를 포함하는 항균 조성물
KR101151516B1 (ko) * 2008-12-24 2012-05-30 씨제이제일제당 (주) 신규한 박테리오파지 및 이를 포함하는 항균 조성물

Also Published As

Publication number Publication date
EP2475377A4 (en) 2013-06-26
JP2013503628A (ja) 2013-02-04
CN102596219B (zh) 2014-04-30
JP5613767B2 (ja) 2014-10-29
BR112012004945B8 (pt) 2021-05-25
US20110052544A1 (en) 2011-03-03
WO2011028059A3 (en) 2011-07-14
EP2475377A2 (en) 2012-07-18
ES2562640T3 (es) 2016-03-07
CN102596219A (zh) 2012-07-18
BR112012004945B1 (pt) 2020-11-17
EP2475377B1 (en) 2016-01-06
US8329442B2 (en) 2012-12-11
WO2011028059A2 (en) 2011-03-10

Similar Documents

Publication Publication Date Title
BR112012004945A2 (pt) bacteriófago novo e composição antibacteriana compreendendo o mesmo
BRPI0902901B8 (pt) bacteriófago e composição antibacteriana, alimento para animais, água potável, desinfetante, agente de limpeza e método para tratamento de doenças infecciosas compreendendo o mesmo
BR112013015635A2 (pt) bacteriófago isolado, composição e método de antibiótico para prevenção ou tratamento de doenças infecciosas causadas por uma ou mais linhagens de salmonella, alimentação animal ou água potável e desinfetante ou limpador
BR112013004206A2 (pt) novo bacteriófago isolado contendo atividade bactericida específica de e. coli e composição antibacteriana que compreende o mesmo
BR112014006768A2 (pt) novo bacteriófago e composição antibacteriana compreendendo o mesmo
WO2011028057A3 (en) Novel bacteriophage and antibacterial composition comprising the same
UA111464C2 (uk) Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу
BR112017014649A2 (pt) ?isolado intestinal humano, e, composição?
BR112012032877A2 (pt) uso de ácido chicórico e derivados para regulagem de pigmentação da pele
BR112012007598A2 (pt) composição para promoção da produção de colágeno
PE20141452A1 (es) Cepas de salmonella gallinarum modificadas avirulentas y composiciones farmaceuticas que las usan
BR112018008781A2 (pt) agente antimicrobiano compreendendo xantohumol e o uso do mesmo em produtos alimentícios
BR112017004933A2 (pt) composição de limpeza antimicrobiana e método de limpeza ou desinfecção de uma superfície
WO2011028061A3 (en) Novel bacteriophage and antibacterial composition comprising the same
MX369176B (es) Composiciones fitoquímicas útiles como desinfectantes y conservadores para alimentos.
WO2011028064A3 (en) Novel bacteriophage and antibacterial composition comprising the same
BR112013005532A2 (pt) agente terapêutico para dor
TR200900881A2 (tr) Tadı ve kokusu maskelenmiş stabil farmasötik bileşimler
CL2015001254A1 (es) Composición quelante de arsénico.
BR112016014981A2 (pt) Acelerador de produção de catecolamina e agente preventivo e terapêutico e composição alimentícia preventiva e terapêutica para doenças causadas por deficiência de catecolamina
MX2010009311A (es) Composiciones desinfectantes.
BR112018007213A2 (pt) composto, formulação de fragrância, métodos para melhorar, intensificar ou modificar uma formulação de fragrância e para neutralizar odor desagradável, e, produto de fragrância.
BR112015027837A2 (pt) Combinação de extratos de planta usada como um aditivo para ração
CN103689003A (zh) 一种杀菌剂
BR112014017448A2 (pt) composição dermocosmética contendo como princípio ativo, uma combinação sinérgica de prata coloidal e ácido desoxirribonucleico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/11/2020, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 03/09/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF